Allogene Therapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2022 | 143.1M |
| FY2023 | 156.9M |
| FY2024 | 194.8M |
| FY2025 | 220.6M |
| FY2026 | 243.8M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2022 | 143.1M |
| FY2023 | 156.9M |
| FY2024 | 194.8M |
| FY2025 | 220.6M |
| FY2026 | 243.8M |